The APCS Knockout A-549 Polyclonal Cells are a heterogeneous population of CRISPR/Cas9-edited A-549 cells in which the APCS gene has been disrupted to create a functional loss-of-function model. This polyclonal pool contains diverse editing events across the cell population, providing a robust system for studying the roles of serum amyloid P component (SAP) without clonal effects. The product is not a monoclonal cell line; rather, it represents a pooled knockout population suitable for experiments that benefit from averaged biological variability.
The host A-549 cell line is a human lung adenocarcinoma epithelial line originally derived from a 58-year-old male patient. These cells exhibit an epithelial morphology and a hypotriploid karyotype and are widely employed as a model of type II alveolar epithelial cells. A-549 cells have been extensively used in pulmonary research, including studies on lung cancer biology, respiratory diseases, and drug metabolism. Their responsiveness to inflammatory cytokines, such as IL-6 and TNF-??, makes them particularly relevant for investigating innate immune functions in the lung epithelium.
The APCS gene encodes SAP, a soluble pattern recognition receptor belonging to the pentraxin family. SAP functions as a key mediator of innate immunity by binding to microbial surfaces, nuclear debris, and amyloid fibrils. It facilitates opsonization and phagocytosis through interactions with Fc?? receptors and complement component C1q, while also modulating the classical complement pathway. SAP transcription is regulated by IL-6, IL-1??, and TNF-?? via transcription factors such as NF-??B, C/EBP??, and STAT3. Downstream, SAP influences clearance of apoptotic cells and stabilization of the extracellular matrix through interactions with fibronectin, proteoglycans, and chromatin.
In the context of A-549 lung adenocarcinoma cells, APCS knockout enables dissection of SAP??s contributions to tumor cell biology and the pulmonary inflammatory milieu. Since alveolar epithelial cells are exposed to inhaled pathogens, pollutants, and endogenous danger signals, this model is valuable for investigating how SAP-mediated pattern recognition impacts lung cancer progression, immune evasion, and epithelial-to-mesenchymal transition. Additionally, the model can be used to explore the role of SAP in pulmonary amyloid deposition, as A-549 cells can internalize amyloid fibrils via endocytic mechanisms.
This polyclonal knockout cell product supports a broad range of functional and mechanistic studies. Researchers can employ western blotting, RT-qPCR, and ELISA to confirm APCS disruption and quantify residual SAP protein. Phagocytosis assays using labeled amyloid fibrils or bacteria, in tandem with complement activation assays, allow assessment of SAP-dependent clearance pathways. Immunofluorescence microscopy and flow cytometry can delineate SAP subcellular localization and cell surface receptor expression. Moreover, migration and drug sensitivity assays are well-suited for evaluating how SAP deficiency alters A-549 cell behavior in cancer-relevant contexts. For further information or technical support, please contact Ascent Research.
